Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Exchange Rate Effect (2023 - 2025)

Ironwood Pharmaceuticals' Exchange Rate Effect history spans 3 years, with the latest figure at $351000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 1571.43% year-over-year to $351000.0; the TTM value through Dec 2025 reached -$329000.0, down 928.12%, while the annual FY2025 figure was -$329000.0, 928.12% down from the prior year.
  • Exchange Rate Effect for Q4 2025 was $351000.0 at Ironwood Pharmaceuticals, up from -$26000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $351000.0 in Q4 2025 and bottomed at -$647000.0 in Q2 2025.
  • The 3-year median for Exchange Rate Effect is -$26000.0 (2024), against an average of -$45666.7.
  • The largest YoY upside for Exchange Rate Effect was 1571.43% in 2025 against a maximum downside of 1168.63% in 2025.
  • A 3-year view of Exchange Rate Effect shows it stood at -$50000.0 in 2023, then skyrocketed by 142.0% to $21000.0 in 2024, then surged by 1571.43% to $351000.0 in 2025.
  • Per Business Quant, the three most recent readings for IRWD's Exchange Rate Effect are $351000.0 (Q4 2025), -$26000.0 (Q3 2025), and -$647000.0 (Q2 2025).